APT Medical Inc. (SHA:688617)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Coronary Access	791.10M
Coronary Access Growth	38.98%
Electrophysiology	367.53M
Electrophysiology Growth	25.51%
Peripheral Intervention	256.24M
Peripheral Intervention Growth	40.36%
OEM	210.47M
OEM Growth	31.67%
Non-vascular Intervention	16.39M
Other Business	8.49M
Other Business Growth	-26.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
China	1.42B
China Growth	32.48%
Overseas	234.15M
Overseas Growth	72.66%